Home | Contact Us | Search | Site Map
About Us Technology Products R&D Partners Investors Media Careers Hidden
Crucell
Technology Technology

 

Crucell’s strong product portfolio is supported through a range of patented technologies. Our cutting-edge technology platforms enable the discovery, development and production of vaccines, therapeutic proteins, and gene therapy products.
PER.C6® Technology
PER.C6® technology is Crucell’s core proprietary technology. With over 45 commercial licenses issued on PER.C6® technology, Crucell has set new industry standards for the development and industrial-scale manufacturing of vaccines, recombinant proteins including monoclonal antibodies, and gene therapy products. Read more
Vaccine Technology

Crucell employs a number of proprietary technologies to develop vaccines against viruses, parasites and bacteria. These technologies include:

 

Read more

Protein Technology

Crucell employs a number of proprietary technologies to develop therapeutic proteins, including monoclonal antibody products. These technologies include:

 

Read more

  E-mail this page   Print this page

  |  Home  |  Contact Us  |  Search  |  Site Map  |  
Served by MoveNext © Crucell 2006 | Disclaimer